SOBRsafe (NASDAQ: SOBR), a Colorado-based provider of next-generation transdermal alcohol detection technology, has just announced the launch of its fully integrated enterprise software solution that is expected to transform how health providers monitor and manage…
SOBRsafe (NASDAQ: SOBR), a provider of next-generation transdermal alcohol screening and monitoring solutions, recently raised $8.2 million in gross proceeds from a private placement with certain institutional investors. The company expects to use the net…
SOBRsafe (NASDAQ: SOBR) announced its compliance with Nasdaq’s listing standards, meeting minimum bid price, public float, and stockholders’ equity requirements per the August 2024 Nasdaq Hearings Panel decision. As a result, SOBRsafe’s common stock will…
Early this year, SOBRsafe (NASDAQ: SOBR), a provider of next-generation transdermal alcohol detection solutions, announced that the sale of its SOBRsure(TM) wearable continuous alcohol monitoring device had begun in Australia and New Zealand following a…
In 2015 and 2016, the National Institute on Alcohol Abuse and Alcoholism (“NIAAA”), a part of the National Institutes of Health (“NIH”), challenged innovators and entrepreneurs to create a “wearable or otherwise discreet device capable…
SOBRsafe (NASDAQ: SOBR), a provider of next-generation, transdermal alcohol-detection solutions, has released certain information regarding a private placement. The placement, which is with certain institutional investors, is projected to result in an estimated $8.2 million…
SOBRsafe (NASDAQ: SOBR), a company leveraging its advanced next-generation transdermal alcohol detection technology to empower recovery, recently shared a video update from CEO and Chairman Dave Gandini. In the update, Gandini discussed the company’s approved…
SOBRsafe (NASDAQ: SOBR), the developer of advanced transdermal alcohol detection and monitoring technology, has made substantial progress in 2024. The company has secured 35 new customer accounts this year, a substantial increase over 2023. The…
SOBR Safe (NASDAQ: SOBR) (“SOBRsafe”), a provider of next-generation transdermal alcohol detection solutions, today announced the launch of a new national campaign to introduce the SOBRsafe(TM) technology to behavioral health providers and drive sales growth…
SOBRsafe (NASDAQ: SOBR), the provider of next-generation transdermal alcohol detection solutions, has continued to implement plans and strategies to strengthen its financial position and restructure shareholder equity throughout the second quarter of its 2024 financial…
SOBRsafe (NASDAQ: SOBR), a provider of next-generation, transdermal alcohol-detection solutions, is reporting on its NASDAQ listing, financial positioning and sales progress, noting that the NASDAQ Hearings Panel granted the company an exception period continuing the…
SOBRsafe (NASDAQ: SOBR) provides next-generation transdermal alcohol detection technology, which simplifies the alcohol detection process. The proprietary technology combines an NIAAA-awarded gas sensor with proprietary algorithms to capture alcohol vapor emitted through pores, detecting alcohol 2-3x…
SOBR Safe (NASDAQ: SOBR) (“SOBRsafe(TM)”), a provider of next-generation transdermal alcohol detection solutions, recently closed on a warrant inducement offering. The company received gross proceeds of $2,786,174 from the transaction. Aegis Capital Corp. acted as…
Committed to creating a culture of prevention and support through its suite of advanced touch-based alcohol detection solutions and a powerful backend data platform, SOBRsafe (NASDAQ: SOBR) provides next-generation technology for the behavioral health, judicial and consumer…
SOBRsafe (NASDAQ: SOBR), a provider of next-generation transdermal alcohol detection solutions, recently announced that they have signed a hardware/software agreement with a four-facility behavioral health provider based in Florida. (https://ibn.fm/7cxba). The customer provides the full…
For most of 2023, SOBRsafe (NASDAQ: SOBR), a company that provides next-generation transdermal alcohol detection and monitoring solutions, took a broad approach to marketing its technology, which appeared to have near-universal applicability, according to company Chair…
SOBRsafe (NASDAQ: SOBR), a provider of next-generation transdermal (touch-based) alcohol detection technology, recently announced that ALYST Health, a company that offers the first and only fully at-home addiction treatment program accredited by the Joint Commission,…
SOBRSafe (NASDAQ: SOBR), providers of next-generation transdermal alcohol-detection solutions, is hosting the first segment of its new behavioral-health webinar series. Titled “The Future of Alcohol Monitoring Is Here: Discover Touch-Based Detection with SOBRsafe,” the webinar…
SOBR Safe (NASDAQ: SOBR) (“SOBRsafe(TM)”), a provider of next-generation transdermal alcohol detection solutions, today announced further expansion of its support of the behavioral health continuum of care, entering the psychological services and therapy sector with…
SOBRSafe (NASDAQ: SOBR), providers of next-generation transdermal alcohol detection solutions, has unveiled a new behavioral-health webinar series. The slate of webinars will include industry leaders and focus on cutting-edge best practices. The first segment in…